Loading…
Ashirwad Capital (BSE 512247)₹2.61+1.16%Other Financial Services
Ashirwad Capital is compared with the 10 closest in size in Other Financial Services (126 companies in the industry). It has a P/E of 32.6 against a peer median of 27.4, and ROCE of 6.7% against a peer median of 1.0%, and latest-quarter sales growth of 5.9% against a peer median of 10.8%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Other Financial Services
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Pharmachem Industries | 29 | — | 1.0 | 0.9 | 0.00 | 0.0 | 3 | 1 | — | −84.2 | vs BSE 512247 |
| West Leisure Resorts | 27 | — | 0.5 | 0.3 | 0.00 | 0.1 | 1 | 0 | −91.4 | −88.2 | vs BSE 512247 |
| ISL Consulting | 27 | — | −17.1 | −17.1 | 0.00 | 0.0 | 19 | −2 | −39.8 | — | vs BSE 512247 |
| Bervin Investments & Leasing | 27 | — | −50.0 | −65.9 | 0.22 | 0.0 | 0 | −16 | — | 71.6 | vs BSE 512247 |
| Longspur International Ventures | 26 | 30.4 | 2.3 | 1.8 | 0.33 | 0.0 | 4 | 1 | 15.6 | −15.0 | vs BSE 512247 |
| Ashirwad Capital | 23 | 32.6 | 6.7 | 5.4 | 0.16 | 0.0 | 1 | 1 | 5.9 | 33.3 | — |
| Jindal Capital | 22 | — | 11.1 | 9.8 | 1.15 | 0.0 | 4 | 1 | 74.4 | — | vs BSE 512247 |
| Navigant Corporate Advisors | 22 | 24.5 | 10.3 | 7.3 | 0.00 | 0.0 | 5 | 1 | −37.9 | −53.1 | vs BSE 512247 |
| Roselabs Finance | 22 | — | −166.6 | — | — | 0.0 | 1 | −0 | — | — | vs BSE 512247 |
| KJMC Corporate Advisors (India) | 21 | 10.4 | 5.9 | 3.1 | 0.10 | 0.0 | 12 | 2 | 21.2 | 8.6 | vs BSE 512247 |
| Step Two Corporation | 20 | — | −32.1 | −23.8 | 0.00 | 0.0 | 5 | −2 | 22.9 | −162.8 | vs BSE 512247 |
| Peer median | 23 | 27.4 | 1.0 | 1.3 | 0.05 | 0.0 | 4 | 1 | 10.8 | −34.0 |
Listed companies closest to Ashirwad Capital in Other Financial Services include Biogen Pharmachem Industries, West Leisure Resorts, ISL Consulting, Bervin Investments & Leasing, Longspur International Ventures, Jindal Capital, Navigant Corporate Advisors, Roselabs Finance.
Biogen Pharmachem Industries, with a market cap of ₹29.40 Cr.
Ashirwad Capital trades at a P/E of 32.6; the median of its peer set is 27.4. A P/E above or below the median is a description, not a judgement on value.
Ashirwad Capital's return on capital employed is 6.7%, above the peer median of 1.0%.